Biosig Technologies Inc (BSGM) USD0.001

Sell:$7.11Buy:$7.39$1.59 (27.70%)

Prices delayed by at least 15 minutes
Sell:$7.11
Buy:$7.39
Change:$1.59 (27.70%)
Prices delayed by at least 15 minutes
Sell:$7.11
Buy:$7.39
Change:$1.59 (27.70%)
Prices delayed by at least 15 minutes

Company Information

About this company

BioSig Technologies, Inc. is a medical device technology company. The Company has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.

Key people

Morgan Lekstrom
Chairman of the Board
Henry Mcphie
Chief Executive Officer, Director
Ferdinand Groenewald
Interim Chief Financial Officer
Mitchell Y. Williams
Chief Investment Officer
Anthony Amato
Director
Steven E. Abelman
Independent Director
Chris Baer
Independent Director
Donald F. Browne
Independent Director
Click to see more

Key facts

  • EPIC
    BSGM
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US09073N3008
  • Market cap
    $782.73m
  • Employees
    5
  • Shares in issue
    136.36m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.